Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 78,560 | reported | 18 Mar 2026 | tx 403+1,968,365−1,641,048 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 1,273 | 56.05 USD | |
| 16 Mar 2026 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 14,570 | 0.00 USD | |
| 16 Mar 2026 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 7,177 | 58.51 USD | |
| 16 Mar 2026 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 34,690 | 0.00 USD | deriv |
| 26 Feb 2026 | SALE | BIOMARIN PHARMACEUTICAL INC | 26,061 | 61.36 USD | |
| 25 Feb 2026 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 2,372 | 0.00 USD | |
| 25 Feb 2026 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,675 | 0.00 USD | |
| 25 Feb 2026 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,177 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 375 | 54.14 USD | |
| 14 Mar 2025 | TAX_WITHHOLDING | BIOMARIN PHARMACEUTICAL INC | 16,249 | 69.44 USD | |
| 17 Mar 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 12,940 | 0.00 USD | |
| 17 Mar 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 30,020 | 0.00 USD | deriv |
| 25 Feb 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 9,660 | 0.00 USD | |
| 25 Feb 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 11,040 | 0.00 USD | |
| 25 Feb 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 9,367 | 0.00 USD | |
| 28 May 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 40,850 | 63.10 USD | |
| 28 May 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 2,779 | 75.29 USD | |
| 28 May 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 38,071 | 74.46 USD | |
| 28 May 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 40,850 | 0.00 USD | deriv |
| 02 May 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 1,850 | 85.01 USD | |
| 30 Apr 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 301 | 68.65 USD | |
| 02 May 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 1,850 | 63.10 USD | |
| 02 May 2024 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 1,850 | 0.00 USD | deriv |
| 28 Mar 2024 | SALE | BIOMARIN PHARMACEUTICAL INC | 24,602 | 88.34 USD | |
| 15 Mar 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 10,260 | 0.00 USD |